Karen Spicer Doyle, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4048 Laurel St, Suite #303, Anchorage, AK 99508 Phone: 907-562-4550 |
Lauren Clements, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 161 Klevin St Ste 103, Anchorage, AK 99508 Phone: 907-550-3047 |
Mrs. Jennifer Faggert Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8200 Homer Dr, Suite F, Anchorage, AK 99518 Phone: 907-345-0050 |
Mrs. Randi Wood Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6927 Old Seward Hwy Ste 100, Anchorage, AK 99518 Phone: 907-345-0050 |
Allison Emmert Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12350 Industry Way, Suite 202, Anchorage, AK 99515 Phone: 907-301-4588 |
Speech & Beyond Therapy Services, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3705 Arctic Blvd, #133, Anchorage, AK 99503 Phone: 907-691-8994 |
Martina Rudzinski, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 161 Klevin St Ste 103, Anchorage, AK 99508 Phone: 907-550-3053 |
Rebecca M Hanson, MA/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 201 E 54th Ave Ste 207, Anchorage, AK 99518 Phone: 907-301-3396 Fax: 907-561-3522 |
Alissa Thurman Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4109 Lynn Dr #117, Anchorage, AK 99508 Phone: 907-444-6899 |
Megan Kelley Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-1048 |
Abracadabra Speech Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6823 Tudor Road, Anchorage, AK 99507 Phone: 907-317-3727 |
Michelle Barbara Burch, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 W 41st Ave, Suites 102 & 103, Anchorage, AK 99503 Phone: 907-334-9002 |
Hannah M Johnson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4325 Laurel St, Suite 100, Anchorage, AK 99508 Phone: 907-569-5665 Fax: 907-333-1524 |
Jessica M Bauman, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 3300 Providence Dr Ste B201, Anchorage, AK 99508 Phone: 907-212-3116 Fax: 907-212-2570 |
Mr. Adrian Peter Trotman, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1290 Elegante Ln, El Dorado Suite 1, Anchorage, AK 99501 Phone: 907-947-7314 |
Ms. Gary Bonita Stein, CCC-SP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5530 E No Lights, Ste 16, Anchorage, AK 99504 Phone: 907-742-4000 Fax: 907-742-4001 |
Samantha Matteucci, MS, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 4441 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-7408 Fax: 907-729-8607 |
Anne Lisa Ver Hoef, MA, CCC-SLP Speech-Language Pathologist Medicare: May Accept Medicare Assignments Practice Location: 5820 Yukon Rd, Anchorage, AK 99507 Phone: 907-345-4422 Fax: 907-345-4422 |
Angela Gill Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 4155 Tudor Centre Dr, #103, Anchorage, AK 99508 Phone: 907-729-1269 |
Mrs. Alison Nicole Kee, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12580 Old Seward Hwy, Anchorage, AK 99515 Phone: 907-301-4588 |
News Archive
As perceived by both patients and doctors, the cosmetic results after "lumpectomy" for breast cancer differ for African-American versus Caucasian women, suggests a pilot study in the Plastic and Reconstructive Surgery-Global Open-, the official open-access medical journal of the American Society of Plastic Surgeons (ASPS).
Alere Inc., a global leader in rapid diagnostics, today announced the launch of its Alereā¢ Malaria Ag P.f, a major technological breakthrough in high-sensitivity rapid testing versus currently available malaria RDTs.
Human Genome Sciences, Inc. will today announce its priority goals for 2012 and report on progress with the commercialization of BENLYSTA (belimumab), the first approved drug for systemic lupus in 56 years, during a presentation this afternoon by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 30th Annual JPMorgan Healthcare Conference in San Francisco.
Eli Lilly and Company announced that The Lancet Oncology has published results of the Phase III REACH trial that evaluated CYRAMZA (ramucirumab) as a second-line treatment for people with hepatocellular carcinoma (HCC), also known as liver cancer. While the REACH trial's primary endpoint of overall survival favored the CYRAMZA arm, it was not statistically significant.
Add an improved memory to the list of the many benefits that accompany having a sense of purpose in life.
› Verified 3 days ago